New biopolymer liquid bandage has received FDA approval

A liquid skin bandage has been approved for licensing and sale by the U.S. Food and Drug Administration (FDA). Known as ElaSkin, the biopolymer liquid bandage is the first commercial product by the biomaterials and medical device start-up, Aleo BME. ElaSkin possesses a variety of characteristics that help make it a “best-in class technology,” said CEO Chao Liu. Among these are its quick drying, simple and clean removal, elasticity, transparency, and durability against bacteria. These are on top of its strength and sturdiness, and the level of comfort that it can provide.

All of these and several other qualities have helped make it a true innovation as a liquid bandage. So much so that Liu has said that ElaSkin has the potential for applications outside of the medical. “We’ve found a lot of uses for this science, but the breadth and growth of the wound care market makes it a great place to start,” stated Liu.